Literature DB >> 18286869

Validation of the alcohol use disorders identification test and the drug abuse screening test in first episode psychosis.

Clifford M Cassidy1, Norbert Schmitz, Ashok Malla.   

Abstract

OBJECTIVE: To determine the validity and reliability of the Alcohol Use Disorders Identification Test (AUDIT) and Drug Abuse Screening Test (DAST) for detecting alcohol and drug use disorders, respectively, in a population with first-episode psychosis (FEP).
METHOD: Subjects with FEP completed the AUDIT and DAST and were divided into groups according to the presence or absence of a Structured Clinical Interview for DSM-IV (SCID) diagnosis of either current alcohol or drug misuse. The data were analyzed to see whether AUDIT and DAST scores were predictive of SCID diagnosis.
RESULTS: Patients with alcohol-related SCID diagnoses and those with drug-related SCID diagnoses scored significantly higher on the AUDIT and DAST, respectively, than the group without the respective SCID diagnosis (P < 0.001 in both cases). The AUDIT functioned best with a problem drinking cut-off score of 10 (sensitivity, 85%; specificity, 91%). The DAST functioned best with a problem drug use cut-off score of 3 (sensitivity, 85%; specificity, 73%). The area under the receiver operating characteristic curve was 0.86 for the AUDIT and 0.83 for the DAST.
CONCLUSION: The DAST and AUDIT may reliably identify FEP patients with substance abuse.

Entities:  

Mesh:

Year:  2008        PMID: 18286869     DOI: 10.1177/070674370805300105

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  10 in total

1.  Unhealthy drug use: how to screen, when to intervene.

Authors:  Aleksandra Zgierska; Iliya Paul Amaza; Richard L Brown; Marlon Mundt; Michael F Fleming
Journal:  J Fam Pract       Date:  2014-09       Impact factor: 0.493

Review 2.  Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review.

Authors:  Shannon M Smith; Florence Paillard; Andrew McKeown; Laurie B Burke; Robert R Edwards; Nathaniel P Katz; Elektra J Papadopoulos; Bob A Rappaport; Ashley Slagle; Eric C Strain; Ajay D Wasan; Dennis C Turk; Robert H Dworkin
Journal:  J Pain       Date:  2015-02-04       Impact factor: 5.820

3.  Performance of the alcohol use disorders identification test among tuberculosis patients in Russia.

Authors:  Trini Mathew; Alan Shields; Sergey Yanov; Vera Golubchikova; Aivar Strelis; Galina Yanova; Sergey Mishustin; Garrett Fitzmaurice; Hilary Connery; Sonya Shin; Shelly F Greenfield
Journal:  Subst Use Misuse       Date:  2010-03       Impact factor: 2.164

4.  Calcium-dependent intracellular signal pathways in primary cultured adipocytes and ANK3 gene variation in patients with bipolar disorder and healthy controls.

Authors:  A Hayashi; K Le Gal; K Södersten; D Vizlin-Hodzic; H Ågren; K Funa
Journal:  Mol Psychiatry       Date:  2014-10-14       Impact factor: 15.992

5.  The validity and reliability of the Mandarin Chinese version of the drug abuse screening test among adolescents in Taiwan.

Authors:  Jung-Yu Liao; Hsueh-Yun Chi; Jong-Long Guo; Chiu-Mieh Huang; Shu-Fang Shih
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-06-06

6.  Hazardous alcohol use in a sample of first episode psychosis patients in Singapore.

Authors:  Laxman Cetty; Shazana Shahwan; Pratika Satghare; Fiona Devi; Boon Yiang Chua; Swapna Verma; Helen Lee; Siow Ann Chong; Mythily Subramaniam
Journal:  BMC Psychiatry       Date:  2019-03-15       Impact factor: 3.630

7.  Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS).

Authors:  Melissa Pyle; Matthew R Broome; Emmeline Joyce; Graeme MacLennan; John Norrie; Daniel Freeman; David Fowler; Peter M Haddad; David Shiers; Chris Hollis; Jo Smith; Ashley Liew; Rory E Byrne; Paul French; Sarah Peters; Jemma Hudson; Linda Davies; Richard Emsley; Alison Yung; Max Birchwood; Eleanor Longden; Anthony P Morrison
Journal:  Trials       Date:  2019-07-04       Impact factor: 2.279

8.  Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trial.

Authors:  Melissa Pyle; John Norrie; Matthias Schwannauer; David Kingdon; Andrew Gumley; Douglas Turkington; Rory Byrne; Suzy Syrett; Graeme MacLennan; Robert Dudley; Hamish J McLeod; Helen Griffiths; Samantha Bowe; Thomas R E Barnes; Paul French; Paul Hutton; Linda Davies; Anthony P Morrison
Journal:  BMC Psychiatry       Date:  2016-08-05       Impact factor: 3.630

9.  Psychometric properties of the Alcohol Use Disorders Identification Test (AUDIT) and prevalence of alcohol use among Iranian psychiatric outpatients.

Authors:  Simasadat Noorbakhsh; Jamal Shams; Mohamadmahdi Faghihimohamadi; Hanieh Zahiroddin; Mats Hallgren; Hakan Kallmen
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-01-30

10.  Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.

Authors:  Anthony P Morrison; Melissa Pyle; Andrew Gumley; Matthias Schwannauer; Douglas Turkington; Graeme MacLennan; John Norrie; Jemma Hudson; Samantha E Bowe; Paul French; Rory Byrne; Suzy Syrett; Robert Dudley; Hamish J McLeod; Helen Griffiths; Thomas R E Barnes; Linda Davies; David Kingdon
Journal:  Lancet Psychiatry       Date:  2018-07-11       Impact factor: 27.083

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.